Wadwa, R P |
| Active, not recruiting | N/A | 36 | US | AIDANET system | University of Colorado, Denver, University of Virginia, University of California, San Francisco | Type 1 Diabetes | 10/24 | 05/25 | | |
Forlenza, Gregory P |
| Recruiting | 3 | 150 | US | iLet Bionic Pancreas System (BP), Usual Care (UC) | Jaeb Center for Health Research, Cystic Fibrosis Foundation, Massachusetts General Hospital, Beta Bionics, Inc. | Cystic Fibrosis-related Diabetes | 11/25 | 03/26 | | |
NCT05006040: HCL Single Arm Pilot Study in Treatment of Hyperglycemia of Pediatric ALL |
|
|
| Terminated | 1 | 1 | US | Hybrid Closed Loop System, Tandem Control-IQ Professional Hybrid Closed Loop system | University of Colorado, Denver, Children's Hospital Colorado, DexCom, Inc., Tandem Diabetes Care, Inc., National Cancer Institute (NCI) | High Risk Acute Lymphoblastic Leukemia | 06/22 | 08/23 | | |
CLVerEx, NCT06177691: Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes (CLVer): Extension Study |
|
|
| Active, not recruiting | N/A | 77 | US | | Jaeb Center for Health Research, Juvenile Diabetes Research Foundation, University of Minnesota | Type1 Diabetes | 12/25 | 12/25 | | |
NCT05403502: Safety Evaluation of an Advanced Hybrid Closed Loop System Using Lyumjev With the Tandem t:Slim X2 Insulin Pump With Control-IQ Technology in Adults, Adolescents and Children With Type 1 Diabetes |
|
|
| Completed | N/A | 183 | US | t:slim X2 insulin pump with Control-IQ technology 1.5 | Tandem Diabetes Care, Inc., Eli Lilly and Company, Jaeb Center for Health Research | Type 1 Diabetes | 08/23 | 08/23 | | |
NCT05683392: Use of Control-IQ Technology 2.0 in Adults, Children, and Preschoolers With Type 1 Diabetes |
|
|
| Completed | N/A | 72 | US | t:slim X2 insulin pump with Control-IQ technology 2.0 | Tandem Diabetes Care, Inc. | Type 1 Diabetes | 12/23 | 12/23 | | |
NCT05325294: Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adults and Pediatrics Utilizing Lyumjev® |
|
|
| Completed | N/A | 244 | US | MiniMed 780G System | Medtronic Diabetes, Eli Lilly and Company | Type 1 Diabetes | 01/24 | 01/24 | | |
NCT05714059: Safety and Effectiveness of the MiniMed™ 780G System With DS5 CGM |
|
|
| Completed | N/A | 250 | US | Insulin Pump with Continuous Glucose Monitoring | Medtronic Diabetes | Type 1 Diabetes | 12/23 | 12/23 | | |
| Recruiting | N/A | 60 | US | Insulin Pump with Continuous Glucose Monitoring | Medtronic Diabetes | Type 1 Diabetes | 06/25 | 06/25 | | |
| Active, not recruiting | N/A | 36 | US | AIDANET system | University of Colorado, Denver, University of Virginia, University of California, San Francisco | Type 1 Diabetes | 10/24 | 05/25 | | |
NCT06719531: SYNERGY PLUS: Evaluation of Next Generation Sensors (NGS) and Algorithm in Patients with Type 1 and Type 2 Diabetes |
|
|
| Not yet recruiting | N/A | 1500 | US | Continuous Glucose Monitoring | Medtronic Diabetes | Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus | 12/25 | 12/25 | | |